Game Creek Capital LP Purchases New Shares in Option Care Health, Inc. $OPCH

Key Points

• Game Creek Capital LP established a new position in Option Care Health by purchasing 55,000 shares in Q3, valued at about $1.53 million per its SEC filing.
• Option Care reported quarterly EPS of $0.46 (meeting estimates) and revenue of $1.47 billion, up 8.8% year‑over‑year, with a 3.67% net margin and 18.57% return on equity.
• Analyst sentiment is broadly positive: MarketBeat shows an average rating of "Moderate Buy" with an average price target of $37.27, and several brokers (e.g., Barrington, Deutsche Bank) recently raised their targets.

Game Creek Capital LP bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 55,000 shares of the company's stock, valued at approximately $1,527,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Cornerstone Planning Group LLC lifted its stake in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock valued at $30,000 after purchasing an additional 1,067 shares during the period. McIlrath & Eck LLC bought a new stake in shares of Option Care Health in the 2nd quarter worth approximately $37,000. Hantz Financial Services Inc. grew its stake in shares of Option Care Health by 987.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company's stock worth $39,000 after buying an additional 1,284 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new position in Option Care Health during the 2nd quarter valued at approximately $40,000. Finally, EverSource Wealth Advisors LLC raised its stake in Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company's stock valued at $46,000 after buying an additional 1,183 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Down 0.3%

OPCH stock opened at $29.29 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The company has a market cap of $4.58 billion, a price-to-earnings ratio of 22.88, a P/E/G ratio of 1.64 and a beta of 0.85. The business's 50-day moving average is $33.58 and its two-hundred day moving average is $30.71. Option Care Health, Inc. has a fifty-two week low of $24.24 and a fifty-two week high of $36.80.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same period in the previous year, the business posted $0.44 earnings per share. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OPCH. Barrington Research raised their price target on Option Care Health from $38.00 to $42.00 and gave the company an "outperform" rating in a report on Friday, January 16th. Wall Street Zen downgraded shares of Option Care Health from a "buy" rating to a "hold" rating in a research note on Saturday, February 28th. TD Cowen reissued a "hold" rating on shares of Option Care Health in a research report on Tuesday, January 27th. National Bank Financial set a $37.00 price objective on Option Care Health in a research report on Tuesday, January 27th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Option Care Health from $31.00 to $36.00 and gave the stock a "buy" rating in a report on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and an average price target of $37.27.

Option Care Health Profile

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.